Study to Evaluate Satisfaction of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Study Title

Study to Evaluate Satisfaction and Usability of DuoRespֲ® SPIROMAXֲ® in Asthma and COPD Treatment

Teva Identifier

BFS-AS-40074 | DRKS00006542

ClinicalTrials.gov Identifier

NCT02384577

Study Status

Completed

Trial Condition(s)

Patient Satisfaction

Interventions

Drug: Budesonide, Formoterol Fumarate Dihydrate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
disease icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

07/01/2014 - 09/01/2016

Study Type

Observational